我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Stereotactic Body actinotherapy for the Definitive Treatment of Early Stage excretory organ Cancer: A Survival Comparison with Surgery

Henry Austen

Partial excision is that the most well-liked definitive treatment for early stage excretory organ cancer, with neoplasm ablative techniques or active police investigation reserved for patients not undergoing surgery. Stereotactic body irradiation (SBRT) has emerged as a possible noninvasive various for patients with early stage excretory organ cancer not amenable to surgery, with early reports suggesting glorious rates of native management and restricted toxicity.The national cancer information from 2004 to 2014 was queried for patients UN agency received an identification of excretory organ cancer. Treatments were categorised as surgery (partial or total nephrectomy), neoplasm ablation (cryoablation or thermal ablation), SBRT (radiation medical care in five fractions or less to a complete biological effective dose [BED10] of seventy two or more), or observation. A propensity score was generated by multinomial logistical regression. A Cox proportional hazards model was suited verify association between overall survival and treatment cluster with propensity score changes for patient, demographic, and treatment characteristics.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。